ÂÜÀòÂÒÂ×

Devin Sok currently serves as the Head of Science at Global Health Investment Corporation since May 2024. Previously, Devin held multiple roles at the International AIDS Vaccine Initiative (IAVI) from July 2014 to May 2024, including Vice President of Discovery and Innovation and Executive Director of Antibody Discovery and Development. Earlier experience includes positions at The Scripps Research Institute from August 2008 to May 2014, where Devin completed a PhD in Microbiology and Immunology, focusing on the isolation and characterization of HIV broadly neutralizing antibodies for vaccine design under the guidance of advisor Dennis R. Burton. Devin obtained a Bachelor's degree in Chemistry from Stanford University in 2008.